万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>医卫科学>>生物医学工程

生医工交叉与探索(英文)(Med-X) (官网投稿)

简介
  • 期刊简称待设置
  • 参考译名待设置
  • 核心类别 目次收录(知网),外文期刊,
  • IF影响因子待设置
  • 自引率待设置
  • 主要研究方向待设置

主要研究方向:

等待设置主要研究方向
待设置

《生医工交叉与探索(英文)》(Med-X),创刊于2023年,是由上海交通大学与Springer Nature出版平台合作创办的国际开源期刊。Med-X 期刊旨在办成生物医学工程领域的综合性国际顶刊,报道生物医学工程领域的突破性新发现和新技术,搭建高水平学术交流和传播平台,推动生物医学工程学科的交叉融合与创新发展,服务于人类生命健康。期刊接收各类稿件,包括研究论文、通讯、综述、观点、评论和临床报道等类型文章。
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、官网网址:https://www.springer.com/journal/44258

3、投稿系统:https://www.editorialmanager.com/medx/

4、出刊日期:官方未公布刊期信息。

5、微信公众号:Med X 生医工交叉与探索

(微信公众号“上海交通大学生物医学工程学院”公布)

2023714日星期五

                        

 

Med-X期刊信息

【微信公众号“上海交通大学生物医学工程学院”信息】

 

Med-X 期刊是由上海交通大学与Springer Nature出版平台合作创办的国际开源期刊。Med-X 期刊旨在办成生物医学工程领域的综合性国际顶刊,报道生物医学工程领域的突破性新发现和新技术,搭建高水平学术交流和传播平台,推动生物医学工程学科的交叉融合与创新发展,服务于人类生命健康。20229月,期刊成功被评选为中国科技期刊卓越行动计划高起点新刊,意味着本期刊在生物医学工程领域的学术质量和潜力被认可。

Med-X 期刊由上海交通大学副校长、讲席教授徐学敏及美国加州大学洛杉矶分校生物工程系主任、校长讲席教授李松共同担任主编。上海交通大学生物医学工程学院讲席教授郑诚功、长聘教授童善保、UCLA生物工程系副主任Dino Di Carlo教授担任执行主编。期刊组建了由全球一百多位顶尖科学家组成的编委和专业的编辑团队,包括二十多位海内外院士,拟打造世界一流科技顶刊,提升我国生物医学工程学科在全球的学术影响力和领导力。

Med-X 期刊接收各类稿件,包括研究论文、通讯、综述、观点、评论和临床报道等类型文章。期刊将涵盖生物医学工程领域的十个前沿重点专题,分别是:分子与细胞工程,生物材料与组织工程,药物、基因和细胞传递系统,免疫工程,生物力学与机械生物学,生物热科学与工程,生物医学设备与生物传感器,医学机器人、人工智能和远程医疗,生物医学影像学以及生物信息学与计算生物学。

我们热忱欢迎海内外生物医学工程领域

专家和团队投稿!

期刊邮箱:medx@sjtu.edu.cn

期刊官网: https://www.springer.com/journal/44258

期刊微信公众号: Med X 生医工交叉与探索

 

Submission guidelines投稿指南

【官网信息】

 

Instructions for Authors

Article Types

The journal welcomes the article types as below:

Research articles

Reviews

Rapid communication

Case Report

Perspective

Commentary

Back to top

Manuscript Submission

Manuscript Submission

Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.

Permissions

Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.

Online Submission

Please follow the hyperlink “Submit manuscript” on the right and upload all of your manuscript files following the instructions given on the screen.

Please ensure you provide all relevant editable source files. Failing to submit these source files might cause unnecessary delays in the review and production process.

Title Page

Please make sure your title page contains the following information.

Title

The title should be concise and informative.

Author information

The name(s) of the author(s)

The affiliation(s) of the author(s), i.e. institution, (department), city, (state), country

A clear indication and an active e-mail address of the corresponding author

If available, the 16-digit ORCID of the author(s)

If address information is provided with the affiliation(s) it will also be published.

For authors that are (temporarily) unaffiliated we will only capture their city and country of residence, not their e-mail address unless specifically requested.

Large Language Models (LLMs), such as ChatGPT, do not currently satisfy our authorship criteria. Notably an attribution of authorship carries with it accountability for the work, which cannot be effectively applied to LLMs. Use of an LLM should be properly documented in the Methods section (and if a Methods section is not available, in a suitable alternative part) of the manuscript.

……

更多详情:

https://www.springer.com/journal/44258/submission-guidelines


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭